Opus Genetics, Stock Investor Sentiment
| IRD Stock | 1.11 0.06 5.71% |
About 72 percent of all Opus Genetics,'s shareholders are curious in acquiring. The analysis of overall sentiment of trading Opus Genetics, stock suggests that quite a large number of investors are confidant at this time. The current market sentiment, together with Opus Genetics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Opus Genetics, stock news signals to limit their universe of possible portfolio assets.
Opus |
Far too much social signal, news, headlines, and media speculation about Opus Genetics, that are available to investors today. That information is available publicly through Opus media outlets and privately through word of mouth or via Opus internal channels. However, regardless of the origin, that massive amount of Opus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Opus Genetics, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Opus Genetics, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Opus Genetics,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Opus Genetics, alpha.
Opus Genetics, Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Insider Trading | 10/22/2024 |
2 | Shareholder Alert Ademi LLP Investigates Whether Ocuphire Pharma, Inc. Is Breaching Its Duties to Its Public Shareholders | 10/23/2024 |
3 | The RD Fund Announces Ocuphire Pharmas Acquisition of Opus Genetics - StockTitan | 10/25/2024 |
4 | Disposition of 37050 shares by Magrath George of Opus Genetics, at 1.18 subject to Rule 16b-3 | 11/01/2024 |
5 | Acquisition by Yerxa Benjamin R of 332800 shares of Opus Genetics, subject to Rule 16b-3 | 11/07/2024 |
6 | Acquisition by Magrath George of 90294 shares of Opus Genetics, at 1.0102 subject to Rule 16b-3 | 11/15/2024 |
7 | Acquisition by Magrath George of 9706 shares of Opus Genetics, at 1.0244 subject to Rule 16b-3 | 11/18/2024 |
8 | Opus Genetics Inc CEO George Magrath Purchases 100,000 Shares | 11/20/2024 |
9 | Acquisition by Yerxa Benjamin R of 10000 shares of Opus Genetics, at 0.9834 subject to Rule 16b-3 | 11/21/2024 |
10 | Opus Genetics president Benjamin Yerxa acquires 9,834 in stock | 11/25/2024 |
Complementary Tools for Opus Stock analysis
When running Opus Genetics,'s price analysis, check to measure Opus Genetics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opus Genetics, is operating at the current time. Most of Opus Genetics,'s value examination focuses on studying past and present price action to predict the probability of Opus Genetics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opus Genetics,'s price. Additionally, you may evaluate how the addition of Opus Genetics, to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |